TIVA Versus Inhalational Anesthesia and Tissue Oxygenation in Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

November 1, 2020

Study Completion Date

March 1, 2021

Conditions
Cardiac Anesthesia
Interventions
PROCEDURE

TIVA

During the anesthesia maintenance of the TIVA group, 3 μg.kg-1 fentanyl, 0.01-0.05 mg.kg-1 midazolam, and 0.2 mg.kg-1 rocuronium bromide were applied throughout the operation to keep BIS between 40 and 60, approximately once every 45 minutes.

PROCEDURE

SEVO

During the anesthesia maintenance of the SEVO group, 2-3% sevoflurane (1-2 MAC), 3 μg.kg-1 fentanyl and 0.2 mg.kg-1 rocuronium bromide were applied throughout the operation to keep BIS between 40-60.

Trial Locations (1)

06800

Ankara City Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT05320341 - TIVA Versus Inhalational Anesthesia and Tissue Oxygenation in Cardiac Surgery | Biotech Hunter | Biotech Hunter